JP2018035153A5 - - Google Patents

Download PDF

Info

Publication number
JP2018035153A5
JP2018035153A5 JP2017163690A JP2017163690A JP2018035153A5 JP 2018035153 A5 JP2018035153 A5 JP 2018035153A5 JP 2017163690 A JP2017163690 A JP 2017163690A JP 2017163690 A JP2017163690 A JP 2017163690A JP 2018035153 A5 JP2018035153 A5 JP 2018035153A5
Authority
JP
Japan
Prior art keywords
genus
versus
graft
host disease
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017163690A
Other languages
English (en)
Japanese (ja)
Other versions
JP6408092B2 (ja
JP2018035153A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018035153A publication Critical patent/JP2018035153A/ja
Publication of JP2018035153A5 publication Critical patent/JP2018035153A5/ja
Application granted granted Critical
Publication of JP6408092B2 publication Critical patent/JP6408092B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017163690A 2016-08-29 2017-08-28 糞便微生物叢を含む組成物 Active JP6408092B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016166656 2016-08-29
JP2016166656 2016-08-29

Publications (3)

Publication Number Publication Date
JP2018035153A JP2018035153A (ja) 2018-03-08
JP2018035153A5 true JP2018035153A5 (enExample) 2018-05-17
JP6408092B2 JP6408092B2 (ja) 2018-10-17

Family

ID=61565352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017163690A Active JP6408092B2 (ja) 2016-08-29 2017-08-28 糞便微生物叢を含む組成物

Country Status (2)

Country Link
US (2) US20180185421A1 (enExample)
JP (1) JP6408092B2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3062063B1 (fr) * 2017-01-26 2019-04-19 Centre National De La Recherche Scientifique Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques
CA3099880A1 (en) * 2018-06-14 2019-12-19 4D Pharma Research Ltd Compositions comprising bacterial strains
MX2018010105A (es) * 2018-08-21 2020-02-24 Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C Sistema de estabilización de microbiota intestinal humana.
US12144834B2 (en) 2018-09-13 2024-11-19 Xbiome Inc. Methods and compositions for treating gastrointestinal and inflammatory disorders
ES3023261T3 (en) * 2019-05-06 2025-05-30 Theriva Biologics Inc Beta-lactamase compositions for treatment of graft versus host disease
CN115461064A (zh) * 2019-11-26 2022-12-09 东京都 针对移植物抗宿主病的预防或治疗用组合物
US20230043598A1 (en) * 2019-12-23 2023-02-09 Hengameh Chloe LAURIDSEN Capsule comprising a faecal composition
JP2024037266A (ja) * 2022-09-07 2024-03-19 日本電気株式会社 情報処理装置、情報処理方法、およびプログラム

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
EP1671648A4 (en) * 2003-10-02 2009-07-08 Eisai R&D Man Co Ltd PREVENTION AND TREATMENT OF GVHD
WO2011151941A1 (ja) * 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
EP2785828B1 (en) * 2011-12-01 2020-04-08 The University of Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
JP2016501852A (ja) * 2012-11-26 2016-01-21 トーマス・ジュリアス・ボロディ 糞便微生物叢の回復のための組成物、ならびにそれらを作製および使用する方法
AU2014239883B2 (en) * 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
HK1220326A1 (zh) * 2013-03-15 2017-05-05 Seres Therapeutics, Inc. 基於网络微生物组成和方法
CN111265531B (zh) * 2013-10-25 2023-11-10 药品循环有限责任公司 治疗和预防移植物抗宿主病的方法
MX2016005824A (es) * 2013-11-04 2016-11-18 Isopogen Pty Ltd Metodo de cultivo celular.
AU2015353465B2 (en) * 2014-11-25 2021-07-29 Memorial Sloan-Kettering Cancer Center Intestinal microbiota and GVHD
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome

Similar Documents

Publication Publication Date Title
JP2015527308A5 (enExample)
JP2021527104A5 (enExample)
FI3146065T3 (fi) Menetelmiä ja koostumuksia clostridium difficile -infektion vähentämiseksi
JP2018039833A5 (enExample)
JP2018100276A5 (enExample)
JP2015213501A5 (enExample)
JP2018012698A5 (enExample)
WO2015134808A3 (en) Probiotic formulations and methods for use
JP2016523252A5 (enExample)
JP2019526543A5 (enExample)
JP2016529309A5 (enExample)
CO6251326A2 (es) Un exopolisacarido
RU2016143195A (ru) Применение lactobacilius rhamnosus для стимулирования восстановления разнообразия кишечной микробиоты после дисбактериоза
RU2018121036A (ru) Комбинированная пре- и пробиотическая композиция
MX383749B (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas
WO2015121458A3 (fr) Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
CN110177765A (zh) 一种复合材料及其制备方法及用途
WO2016198170A8 (en) Vaccines against streptococcus pneumoniae serotype 5
JP2021535175A5 (enExample)
JP2020513780A5 (enExample)
JP2013523758A5 (enExample)
JP2015521034A5 (enExample)
JP2020137724A5 (enExample)
EP4470625A3 (en) A pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting
CA3010537A1 (en) Vaccine strains of brachyspira hyodysenteriae